Related references
Note: Only part of the references are listed.Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Robert Kueffner et al.
NATURE BIOTECHNOLOGY (2015)
Network topology and parameter estimation: from experimental design methods to gene regulatory network kinetics using a community based approach
Pablo Meyer et al.
BMC SYSTEMS BIOLOGY (2014)
A community effort to assess and improve drug sensitivity prediction algorithms
James C. Costello et al.
NATURE BIOTECHNOLOGY (2014)
The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML
Friederike Pastore et al.
PLOS ONE (2014)
Toward better benchmarking: challenge-based methods assessment in cancer genomics
Paul C. Boutros et al.
GENOME BIOLOGY (2014)
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription
Daniel Thomas et al.
BLOOD (2013)
Mutational landscape of AML with normal cytogenetics: Biological and clinical implications
Maria Paola Martelli et al.
BLOOD REVIEWS (2013)
Systematic Analysis of Challenge-Driven Improvements in Molecular Prognostic Models for Breast Cancer
Adam A. Margolin et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Wisdom of crowds for robust gene network inference
Daniel Marbach et al.
NATURE METHODS (2012)
Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia
Steven M. Kornblau et al.
BLOOD (2011)
The self-assessment trap: can we all be better than average?
Raquel Norel et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid Leukemia
Steven M. Kornblau et al.
CLINICAL CANCER RESEARCH (2010)
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
Sophie Park et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Towards a Rigorous Assessment of Systems Biology Models: The DREAM3 Challenges
Robert J. Prill et al.
PLOS ONE (2010)
Revealing strengths and weaknesses of methods for gene network inference
Daniel Marbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Variable slope normalization of reverse phase protein arrays
E. Shannon Neeley et al.
BIOINFORMATICS (2009)
Functional proteomic profiling of AML predicts response and survival
Steven M. Kornblau et al.
BLOOD (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients
Jerome Tamburini et al.
BLOOD (2007)
Non-parametric quantification of protein lysate arrays
Jianhua Hu et al.
BIOINFORMATICS (2007)
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
Raoul Tibes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
